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Abstract
Growing evidence supports other regulatory roles for protein ubiquitination in addition to
serving as a tag for proteasomal degradation. In contrast to other common post-translational
modifications, such as phosphorylation, little is known about how non-degradative ubiquitina-
tion modulates protein structure, dynamics, and function. Due to the wealth of knowledge
concerning protein kinase structure and regulation, we examined kinase ubiquitination using
ubiquitin remnant immunoaffinity enrichment and quantitative mass spectrometry to identify
ubiquitinated kinases and the sites of ubiquitination in Jurkat and HEK293 cells. We find that,
unlike phosphorylation, ubiquitination most commonly occurs in structured domains, and on
the kinase domain, ubiquitination is concentrated in regions known to be important for regu-
lating activity. We hypothesized that ubiquitination, like other post-translational modifications,
may alter the conformational equilibrium of the modified protein. We chose one human
kinase, ZAP-70, to simulate using molecular dynamics with and without a monoubiquitin
modification. In Jurkat cells, ZAP-70 is ubiquitinated at several sites that are not sensitive to
proteasome inhibition and thus may have other regulatory roles. Our simulations show that
ubiquitination influences the conformational ensemble of ZAP-70 in a site-dependent man-
ner. When monoubiquitinated at K377, near the C-helix, the active conformation of the ZAP-
70 C-helix is disrupted. In contrast, when monoubiquitinated at K476, near the kinase hinge
region, an active-like ZAP-70 C-helix conformation is stabilized. These results lead to test-
able hypotheses that ubiquitination directly modulates kinase activity, and that ubiquitination
is likely to alter structure, dynamics, and function in other protein classes as well.
Author Summary
Attachment of ubiquitin to another protein is typically used to mark the protein for degra-
dation by the proteasome. However, recent studies show that many proteins are tagged
with ubiquitin and not degraded. We hypothesized that ubiquitin can regulate the protein
it is attached to by changing its structure and dynamics. We performed proteomics
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experiments to identify all of the kinase proteins tagged by ubiquitin in a human cell line
as well as the site of ubiquitination. We found that kinases are often ubiquitinated in struc-
tured regions important for regulation and activity. We then performed molecular dynam-
ics simulations of one kinase, ZAP-70, to see if a ubiquitin tag could affect the kinase
structure. We found that ubiquitin does affect the structure of ZAP-70, and the effect
depends on where the ubiquitin is attached. At K377, ubiquitin changes the ZAP-70 struc-
ture to resemble the inactive state, while ubiquitin attached at K476, on the other side of
the protein, has the opposite effect. These simulations indicate that ubiquitin, like other
post-translational modifications, may alter the structure and dynamics of proteins in ways
that impact activity and function.
Introduction
The best-characterized function of ubiquitin is as a marker for protein degradation. The 76-res-
idue ubiquitin protein can be covalently attached at its C-terminus to a lysine side chain amine
group or N-terminus of another protein. Typically, additional ubiquitin molecules are also
attached to the first ubiquitin, forming a polyubiquitin chain. The polyubiquitinated protein is
then targeted to the proteasome for degradation, although ubiquitination can also result in
lysosomal degradation [1–3]. Ubiquitin tagging for selective degradation is crucial to the regu-
lation of many cellular processes [4].
Recently, alternate roles for ubiquitination that are not associated with degradation have
gained attention. In 1992, Varshavsky et al. postulated that ubiquitin might have additional
functions beyond proteasome targeting and that it might perturb the conformation of the pro-
teins to which it is linked [5]. The residue linking two ubiquitin molecules along the polyubiqui-
tin chain can influence whether the ubiquitinated protein is targeted for proteasomal
degradation. The most common linkage, on K48, is closely associated with degradation by the
proteasome [6]. K6, K11, K27, and K23 linkages have not been studied as extensively, but may
also be associated with proteasomal degradation [7,8]. Levels of K63-linked ubiquitination, how-
ever, are not affected by proteasomal inhibition, suggesting alternate functions [6–8]. K63-linked
polyubiquitination is also associated with protein trafficking, DNA repair, and inflammation [7].
Monoubiquitination also is not typically associated with degradation, and in some cases may
regulate protein function by impeding or facilitating protein-protein association [8–10]. Finally,
several ubiquitin-like proteins, such as NEDD8 and SUMO[3], are known to modify proteins in
a similar manner to ubiquitin, and regulate function independent of degradation.
Several pathways have been identified in which ubiquitination influences function. One
example is calmodulin, which is site-specifically and reversibly monoubiquitinated, reducing
its activity toward phosphorylase kinase [11]. Non-degradative ubiquitination both positively
and negatively regulates the TGF-β signaling pathway through mono and polyubiquitinated
Smad proteins [12–14]. TAK1 polyubiquitination with a K63 linkage also regulates TGF-β sig-
naling by activating TAK1 [15]. These ubiquitin modifications may modulate protein-protein
interactions within the pathway, or directly induce conformational changes in the modified
protein. A second example of non-degradative ubiquitination controlling function is the T cell
receptor-zeta (TCR-zeta), which is polyubiquitinated by Cbl-b and Itch with a K33 linkage.
This modification regulates TCR-zeta phosphorylation and its association with protein kinase
ZAP-70 in a non-proteolytic manner [16–18]. Rather than inducing degradation, the ubiquitin
chain promotes phosphorylation, possibly by interacting with the kinase Lck, or by altering the
conformation of the TCR-zeta.
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There are several possible mechanisms for how ubiquitin might regulate protein function
independent of degradation. Computational structural modeling suggests that ubiquitination
can directly affect protein function by blocking a functional domain or active site, sterically pre-
venting oligomerization, preventing target protein binding, or restricting protein flexibility [19].
A perspective by Chernorudskiy and Gainullin details examples of ubiquitination that regulates
protein structure and function without involvement of a ubiquitin binding domain (UBD) [20].
Monoubiquitination of histone H2B has a steric effect, preventing chromatin compaction which
allows increased methylation of histone H3, and does not depend on recognition by a UBD
[21,22]. Ras is another example of activation by site specific monoubiquitination [23]. Different
Ras GTPase isoforms are monoubiquitinated at distinct sites which result in distinct mecha-
nisms of Ras activation, and chemical attachment of monoubiquitin at these sites recapitulates
this result [24,25]. This suggests a conformational change that is different depending on the ubi-
quitination site. Alpha-synuclein also shows a conformational dependence on ubiquitination
site in terms of propensity to form fibrils and oligomers [26]. Certain ubiquitination sites on
alpha-synuclein result in proteasomal degradation, while other sites do not [27].
Crystal structures of these ubiquitinated proteins would be very useful for determining what
conformational changes occur upon ubiquitination and how these affect function. Two crystal
structures of monoubiquitinated constructs have been solved for proliferating cell nuclear anti-
gen (PCNA) [28,29]. These structures show that the ubiquitin is flexible, interacting with
PCNA through the canonical hydrophobic patch at I44 or extended away from PCNA due to
electrostatic repulsion, which is consistent with SAXS data [29,30]. The structures show
changes in PCNA conformation upon ubiquitination, and mutational studies indicate that the
ubiquitin hydrophobic patch can directly interact with the polymerase, facilitating polymerase
exchange. The ubiquitin moiety also provides a steric restriction on proteins interacting with
PCNA. A recent combined SAXS and computational study shows that SUMOylation has a dif-
ferent effect on PCNA conformation than ubiquitination [31]. A crystal structure of SUMOy-
lated thymine DNA glycosylase (TDG) also reveals a conformational change in the modified
protein caused by attachment of the SUMOmoiety [32]. SUMOylation of the TDG C-terminal
domain results in formation of a helix at the TDG-SUMO interface that disrupts TDG function
[32], a mechanism which could also occur in ubiquitination. Crystal structures of ubiquitin
conjugated to an E2 ubiquitin conjugating enzyme [33] and a HECT E3 ubiquitin ligase
[34,35], reveal that a ubiquitinated protein can form a compact interaction with ubiquitin with
the canonical hydrophobic patch either buried or solvent exposed.
Although no crystal structures of a polyubiquitinated target protein are available, many
structural studies have been performed on polyubiquiitn chains on their own, which have impli-
cations for the biophysical consequences of polyubiquitination. K48-linked diubiquitin and tet-
raubiquitin both adopt compact, globular conformations with the ubiquitin moieties bound
together, burying the I44 hydrophobic patch at the interdomain interface [36–38]. However,
other linkages form different conformations as a polyubiquitin chain. K63-linked diubiquitin
adopts an open, extended conformation, and as a tetrameric chain it fluctuates between
extended and compact conformations [39–44]. The rarer linkages have not been studied as
thourghly, but K33-linked, K29-linked and linear diubiquitin are observed to adopt extended
structures without significant contacts between the ubiquitin monomers, similarly to K63
[39,45]. In crystal structures, K11 and K6-linked diubiquitin chains form compact conforma-
tions that are globular, but distinct from K48-linked diubiquitin [46,47]. From these polyubiqui-
tin structures, it seems likely that K48-linked polyubiquitin would have a different physical
effect on its target than K63-linked polyubiquitin or one of the other linkages that adopts an
extended conformation. In an extended structure, it is possible that only the proximal ubiquitin
domain in the polyubiquitin chain would directly interact with the target protein.
Non-degradative Ubiquitination of Protein Kinases
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In this work, we focus on ubiquitin modifications of protein kinases, because many mecha-
nisms for kinase regulation have been characterized previously. The role of post-translational
modifications (PTM), especially phosphorylation, in regulating kinase activity has been exten-
sively investigated. A common site of kinase phosphorylation is the activation loop, where the
introduction of the negatively charged phosphate is usually critical to complete activation [48].
Other examples of kinase regulation induced by phosphorylation include activation by releas-
ing an autoinhibitory element (PKA, PKC, EphB2 and TGF-β receptor tyrosine kinases) [48–
50], inactivation by sterically hindering access to the active site (CDKs) [51], inactivation by
triggering association with an autoinhibitory domain (Src kinases) [48,52], and inactivation by
inhibiting dimerization (DAPK2) [53]. Phosphorylation at one site can also affect phosphory-
lation at another site, as in the case of AMPKα, where phosphorylation at S485 or S173 reduces
phosphorylation of the activation loop (T172) [54]. Beyond phosphorylation, lysine acetylation
can also play a role in kinase regulation. For example, AMPK is inhibited by acetylation of a
regulatory subunit [54,55].
Studies of kinase regulation by ubiquitination have demonstrated decreased kinase activity
by triggering proteasomal or lysosomal degradation, as in the case of tyrosine kinase cell sur-
face receptors [56] and AMPK [54]. Ubiquitination of Sic1 activates the cyclin-CDk protein
complex, when Sic1 dissociates from the complex before being degraded by the proteasome
[57]. However, there are also indications that ubiquitin and ubiquitin-like proteins can regulate
kinases in a degradation-independent manner. In T cells, Cbl-b ubiquitinates and negatively
regulates PI3-kinase, and this is not associated with degradation [56]. SUMOylation was found
to increase activity of AMPK-β by increasing activation loop phosphorylation [54].
Recent developments in mass spectrometry and antibody enrichment of samples for ubiqui-
tinated proteins have enabled several cell-wide proteomics studies of ubiquitinated proteins
[8,58–61]. These experiments identify the precise site of ubiquitination on the protein and can
indicate whether that ubiquitination site is associated with proteasomal degradation; however,
they lack the ability to distinguish between mono and polyubiquitination. Kim et al. found that
42% of the ubiquitination sites in their study did not increase by more than 2-fold when the
proteasome was inhibited, indicating that ubiquitination at these sites may have a function
other than proteasomal degradation. In particular, they observed that when ubiquitin itself was
ubiquitinated at K63 (indicating K63-linked polyubiquitination of an unknown target), this
was not associated with proteasomal degradation [8].
In this study, we report proteomics data on ubiquitination of 132 kinases in Jurkat and cells,
both in the presence and absence of the proteasome inhibitor MG132. We identify many ubi-
quitination sites on protein kinases that do not increase substantially upon treatment with
MG132. Combining our data with previously published data from the PTMfunc database [60],
we find 107 kinase ubiquitin modifications that are proteasome sensitive, and 103 that are pro-
teasome insensitive. This suggests that ubiquitination of some kinases likely has a downstream
effect other than proteasomal degradation. The sites of ubiquitination are most commonly
found within folded protein domains, as has been observed of ubiquitination generally [60,62–
64]. In the kinase domains, these sites are also concentrated in regions known to be important
for regulating activity.
We hypothesized that ubiquitination, like other PTMs such as phosphorylation and acetyla-
tion, modulates the conformation and dynamics of the protein to which they are attached.
Molecular dynamics (MD) simulations have been used to study the ways in which phosphory-
lation changes protein energy landscapes, and to thereby obtain new insights into the mecha-
nisms by which phosphorylation affects protein function [65–69]. The primary effect of
phosphorylation on the energy landscape is often electrostatic because the phosphate group
introduces a -2 charge, which can disrupt hydrogen-bonding networks or introduce new
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stabilizing interactions. Using MD, lysine acetylation has also been shown to have allosteric
effects on protein conformation and influence conformational stability [70,71].
Ubiquitin differs from these well-characterized modifications in that it is much larger and
attached via a short but flexible linker, and it can be extended as a polyubiquitin chain with dif-
ferent linkage types. To begin exploring the ways in which ubiquitin modulates protein struc-
ture and dynamics, we performed a series of MD simulations for one kinase from our
proteomics data, ZAP-70 tyrosine kinase, because it is ubiquitinated at several sites that are
proteasome insensitive. ZAP-70 is a member of the Syk gene family of protein tyrosine kinases
involved in T cell development and activation [72]. It consists of a kinase domain and two SH2
domains, which bind to the hinge region of the kinase, trapping it in an inactive conformation
[73–77]. This autoinhibition is released when the SH2 domains bind to the phosphorylated
form of the TCR complex ITAMs [75,76,78–80]. The SH2 domains detach from the kinase
domain, exposing two conserved tyrosine residues on the linker between the SH2 and kinase
domains, which are subsequently phosphorylated [72,73,75–77]. The crystal structure of the
unphosphorylated ZAP-70 kinase domain without the SH2 domains bound adopts an active-
like conformation [76,81]; however, phosphorylation on Y493 on the activation loop is
required for full activation [72,75,76]. The downstream effect of ZAP-70 activation is Cbl phos-
phorylation and ultimately T cell activation [72]. Although a few studies have noted that ZAP-
70 can be ubiquitinated in vivo [18,82,83], no one has examined how ubiquitination affects
ZAP-70 conformation or activity. We performed MD simulations of two different monoubi-
quitinated constructs of ZAP-70 and characterized the sampled conformational ensembles.
The proteomics data does not determine the number of ubiquitin molecules, so we attached
only a single ubiquitin molecule, as this is the minimal possible modification and may have an
effect that is relavent to all types of ubiquitination. These were compared to simulations of the
unmodified ZAP-70 as well as other (non-ubiquitin) modifications to the same sites. The
results demonstrate that ZAP-70 ubiquitination modulates structure and dynamics in a site-
specific manner, and in ways that suggest possible regulation of kinase activity.
Methods
Ubiquitination and protein abundance proteomics experiments
For ubiquitination analysis in Jurkat cells, cells were first SILAC-labeled for at least 10 dou-
blings in either “light”media containing standard amino acids or “heavy”media containing
13C6-lysine and
13C6,
15N4-arginine [84]. Cells were then infected with VSV-pseudotype HIV
(strain NL4-3) virus at a multiplicity of infection of 5. Both “light” and “heavy” cell populations
were infected or mock infected in duplicate. Infected cells were either treated with MG-132
(Millipore) at 10 μM for 4 hours prior to harvest or were left untreated. Cells were harvested 48
hours after infection by lysis in a buffer containing 8 M urea, 0.1 M Tris pH 8.0, 100 mMNaCl,
and protease inhibitors (Complete EDTA-free, Roche). 10 mg of protein as measured by a
Bradford assay (Quick Start Bradford reagent, Bio-Rad) was subjected to trypsin digestion and
ubiquitin remnant immunoaffinity purification with 250 μg of ubiquitin remnant antibody
(Cell Signaling) as previously described [85]. The diglycine remnant against which the ubiqui-
tin remnant antibody was raised is also exposed for NEDD8 and ISG15-modified proteins.
100 μg of each trypsin-digested Jurkat lysate was reserved for protein abundance analysis. Pep-
tides were fractionated by hydrophilic interaction chromatography (HILIC). The peptides were
injected onto a TSKgel amide-80 column (Tosoh Biosciences, 2.0 mm x 15 cm packed with
5 μm particles) equilibrated with 10% HILIC Buffer A (2% ACN, 0.1% TFA) and 90% HILIC
Buffer B (98% ACN, 0.1% TFA) using an AKTA P10 purifier system. The samples were then
separated by a one-hour gradient from 90% HILIC Buffer B to 55% HILIC Buffer B at a flow
Non-degradative Ubiquitination of Protein Kinases
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rate of 0.3 ml/min. Fractions were collected every 1.5 min and combined in 12 fractions based
on the 280 nm absorbance chromatogram. Fraction were evaporated to dryness and reconsti-
tuted in 20 μl of 0.1% formic acid for mass spectrometry analysis.
For ubiquitination analysis in HEK293 cells, a HEK293 cell line was engineered to express
HIV (strain NL4-3) with a tetracycline-responsive promoter element using the pTRE-Tight
TetOn system (Clontech) [86] and a self-inactivating deletion in the 3’UTR to prevent second
round infection (publication forthcoming). All cells were treated with interferon alpha 1 (Cell
Signaling) at 30 ng/ml and for +Dox samples HIV was induced by the addition of doxycycline
(Sigma) at 1 μg/ml for 48 hours. Cells were either treated with MG-132 (Millipore) at 10 μM
for 5 hours prior to harvest or were left untreated. All HEK293 experiments were performed in
duplicate. 1 mg of protein as measured by a Bradford assay (Quick Start Bradford reagent, Bio-
Rad) was subjected to trypsin digestion and ubiquitin remnant immunoaffinity purification
with 31 μg of ubiquitin remnant antibody (Cell Signaling) as previously described [85].
All samples were analyzed on a Thermo Scientific LTQ Orbitrap Elite MS system equipped
with an Easy nLC-1000 HPLC and autosampler system that is capable of maintaining back-
pressures of up to 10,000 psi for high-resolution chromatographic separations. The HPLC
interfaces with the MS system via a nanoelectrospray source. Samples were injected onto a C18
reverse phase capillary column (75 um inner diameter x 25 cm length, packed with 1.9 um
ReproSil Pur C18-AQ particles). Peptides were then separated by an organic gradient from 5%
to 30% ACN in 0.1% formic acid over 112 minutes at a flow rate of 300 nL/min. The mass spec-
trometer collected data in a data-dependent fashion, collecting one full scan in the Orbitrap at
120,000 resolution followed by 20 collision-induced dissociation MS/MS scans in the dual lin-
ear ion trap for the 20 most intense peaks from the full scan. Dynamic exclusion was enabled
for 30 seconds with a repeat count of 1. Charge state screening was employed to reject analysis
of singly charged species or species for which a charge could not be assigned.
Raw mass spectrometry data were analyzed using the MaxQuant software package (version
1.3.0.5) [87]. Data were matched to the SwissProt human reference protein database (down-
loaded on May 15, 2013). MaxQuant was configured to generate and search against a reverse
sequence database for false discovery rate calculations. Standard variable modifications were
allowed for methionine oxidation, and protein N-terminus acetylation. When searching ubi-
quitination samples, a variable modification was also allowed for lysine ubiquitin remnant
addition. A fixed modification was indicated for cysteine carbamidomethylation. Full trypsin
specificity was required. The first search was performed with a mass accuracy of +/- 20 parts
per million and the main search was performed with a mass accuracy of +/- 6 parts per million.
A maximum of 5 modifications were allowed per peptide. A maximum of 2 missed cleavages
were allowed. The maximum charge allowed was 7+. Individual peptide mass tolerances were
allowed. For MS/MS matching, a mass tolerance of 0.5 Da was allowed and the top 6 peaks per
100 Da were analyzed. MS/MS matching was allowed for higher charge states, water and
ammonia loss events. Data were searched against a concatenated database containing all
sequences in both forward and reverse directions with reverse hits indicating the false discovery
rate of identifications. The data were filtered to obtain a peptide, protein, and site-level false
discovery rate of 0.01. The minimum peptide length was 7 amino acids. Results were matched
between runs with a time window of 2 minutes for technical duplicates.
Statistical analysis of proteomics data
The HIV ubiquitination proteomics results from the HEK293 and Jurkat cells were analyzed
using an in-house computational pipeline built for the analysis of post-translationally modified
peptides with mixed effect models, implemented in the MSstats (v2.3.4) Bioconductor package
Non-degradative Ubiquitination of Protein Kinases
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[88]. For both datasets, protein identifiers were converted into modification site identifiers,
contaminant and false positive MaxQuant search results were removed, and all samples were
normalized per cell line by median-centering the log2-transformed MS1-intensity distribu-
tions. Then, the MSstats groupComparison function was run on the Jurkat dataset with the fol-
lowing options: no interaction terms for missing values, no feature interference, unequal
intensity feature variance, restricted technical and biological scope of replication. The HEK293
dataset was processed in a similar fashion with the following options: imputation of missing
values with the mean minimal observed MS1-intensity across samples, no feature interference,
unequal intensity feature variance, restricted technical and biological scope of replication. We
opted not to impute missing values for the SILAC Jurkat dataset since they are less prevalent
due to the nature of SILAC assays.
Structural bioinformatics
In addition to the ubiquitination proteomics data that we collected in Jurkat and HEK293 cells,
we used the PTMfunc database of protein PTMs [60] to identify other PTMs present on
human protein kinases. Functional annotations for some of these PTMs are included in the
PTMfunc database [60]. In-house scripts were used to map PTMs from all human kinases onto
the PKA and ZAP-70 structures based on an alignment using the ClustalW2 multiple sequence
alignment software from EMBL-EBI [89–91]. When mapping PTMs onto the PKA or ZAP-70
structures, any PTM in a location with no alignment to the mapping protein was omitted.
To determine whether a ubiquitination site is associated with proteasomal degradation, we
used data collected in the presence of a proteasome inhibitor (MG-132). Sites whose abundance
was at least two-fold greater in the presence of a proteasome inhibitor compared to control
were categorized as proteasome sensitive, whereas those with a difference of less than two-fold
were categorized as proteasome insensitive. If the same site was proteasome sensitive in one
cell line or condition and proteasome insensitive in another, we categorized it as neither. For
sites that were significantly more abundant in the presence of HIV, we determined the protea-
some sensitivity based on MG-132 sensitivity in the presence of HIV only, since the level of
ubiquitination without HIV present might be very low. We determined whether differences
between groups (such as proteasome-sensitive and insensitive ubiquitin modifications) are sig-
nificant by using the function prop.test in R [92] to find a p-value, which tests whether the pro-
portions in different group are the same.
Molecular dynamics simulations
We performed all-atomMD simulations starting from 9 different ZAP-70 kinase domain con-
structs. We had five constructs built from the active-state crystal structure: no modification
(control), monoubiquitinated at K377, monoubiquitinated at K476, acetylated at K377, and
with an immunoglobulin (Ig) domain from Cardiac Myosin Binding Protein C attached at
K377. We also built four constructs from the inactive-state crystal structure: control, monoubi-
quitinated at K377, monoubiquitinated at K476, and acetylated at K476.
Model building. The starting structure for the active ZAP-70 kinase domain was the crys-
tal structure 1U59 [81]. We replaced the C-terminal residues 601–614 with those from the
inactive structure 4K2R [77] because the 1U59 construct has a His-tag at the C-terminus. We
used the PLOP homology modeling software [93] to predict the conformation of residues 359–
361, which are missing in the 1U59 structure. We removed the crystallographic waters and the
staurosporine ligand and then used Maestro [94] to predict the protonation states of the histi-
dine side chains. For the inactive ZAP-70 kinase domain we used the crystal structure of the
autoinhibited protein, 4K2R [77]. We removed residues 1–327, the SH2 domains, from this
Non-degradative Ubiquitination of Protein Kinases
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structure leaving only the kinase domain. We replaced the missing activation loop, residues
478–518, using the active ZAP-70 structure (1U59). Side chains with steric clashes were
adjusted in Maestro. We removed the phosphoaminophosphonic acid-adenylate ester mole-
cule, phosphate ion, and magnesium ion from the crystal structure to make the inactive system
as similar as possible to the active kinase system.
We prepared the ubiquitinated ZAP-70 structures using a crystal structure of diubiquitin,
3NS8 [95]. In this structure, the C-terminus of the chain A ubiquitin is covalently attached to
the K48 side chain of the chain B ubiquitin. We aligned K48 of 3NS8 chain B with the lysine
residue we wanted to ubiquitinate on the ZAP-70 structure. We then manually replaced the
ZAP-70 lysine coordinates with those from the aligned 3NS8 chain B K48 residue in the PDB
file and changed this residue’s name to UBK. We added the aligned 3NS8 chain A coordinates
to the ZAP-70 PDB file. To create parameters for the UBK modified residue, we started with
the parameters for acetylated lysine [96], which has a chemical structure and partial charges
similar to ubiquitinated lysine. The parameter file was manually modified to contain the cor-
rect number of atoms for ubiquitinated lysine, and the NZ and HZ atomic charges were
decreased slightly, to -0.4957 and 0.3082 respectively, to make the entire residue neutral. We
used the LEaPmodule from Amber [97] to create library files for the UBK residue (S1 File).
We prepared the acetylated ZAP-70 structures by modifying the PDB file manually to
change the residue name from LYS to ACK. We used previously published parameters to simu-
late the acetylated lysine in Amber [96]. We used the LEaPmodule from Amber [97] to create
library files for the ACK residue (SI). To attach the Ig domain at K377 we used the 3CX2 PDB
structure of the Myosin Binding Protein C Ig domain [98]. We aligned its C-terminal residues
(257–258) with the C-terminal structured residues of ubiquitin (72–73) on the ZAP-70
K377-ubiquitinated structure and rotated the Ig domain to relieve steric clashes with the ZAP-
70 kinase. We then manually replaced the ubiquitin coordinates in the ubiquitinated structure
with the Ig domain coordinates, keeping the C-terminal residues of ubiquitin that make up the
linker (74–76) but changing R74 to a glycine. We used the same parameters for the UBK resi-
due that we had for the ubiquitinated constructs.
Simulation protocol. LEaP was used to prepare all structures for simulation, surrounding
the protein with 10 Å of water on all sides and adding Cl- ions to neutralize the system. The
number of water molecules added varied depending on the construct (S1 Table). The structure
was energy minimized and then equilibrated at constant volume while raising the temperature
to 300 K. A constant pressure simulation was then run for 1 ns to equilibrate the system den-
sity. Dimensions of the periodic box after density equilibration for each construct are given in
S1 Table. All MD simulations were performed using the pmemdmodule in the Amber package
[97], Amber99SB force field [99], and explicit TIP3P water representation [100]. The Andersen
thermostat was used to hold the temperature constant at 300 K [101,102], and the Berendsen
barostat with isotropic position scaling and a relaxation time of 1 ps to hold the system at 1 bar
[103]. Particle-mesh Ewald procedure was used to handle long-range electrostatic interactions
with a non-bonded cutoff of 9 Å. Simulations were run on GPUs, which gave the most efficient
performance. After the initial 1 ns equilibration, 8 independent 10-ns simulations were carried
out starting from the equilibrated structure, but with new initial, randomized, velocities. These
10 ns simulations were considered additional equilibration. The final structures from each of
these simulations were used to start 4 new independent simulations of 10 ns, resulting in a total
of 32 independent 10-ns simulations. The trajectories, spanning a total of 320 ns of simulation,
were analyzed for each system with snapshots taken every picosecond. In addition we ran a sin-
gle 100 ns simulation for each of the unmodified ZAP-70 constructs (starting from the active
state crystal structure and starting from the inactive state crystal structure). We also ran a single
560 ns simulation for the active state ZAP-70 construct ubiquitinated at K377 and for the
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inactive state ZAP-70 construct ubiquitinated at K476. These longer simulations were also ana-
lyzed by taking snapshots every picosecond.
Molecular dynamics analysis. We analyzed the MD trajectories using the cpptrajmodule
of Amber [97]. The secondary structure of the ZAP-70 C-helix was determined using the DSSP
criteria described by Kabsch and Sander [104]. In-house scripts were used to analyze the MD
trajectories and the R statistical computing and graphics language [92] was used to plot the
structural fluctuations of the ZAP-70 kinase domain. All histograms were computed by com-
bining all independent trajectories for a given construct (snapshots spaced every picosecond)
and binning over this total ensemble of structures. To determine whether the distribution of
various structural metrics differed between simulations of different ZAP-70 constructs, we
treated the mean value from each of the 32 independent simulations as a single data point. We
then used the function wilcox.test in R, which performs a Wilcoxon rank sum test, to test the
difference between the distributions for different constructs. We performed the statistical test
on the mean of each independent simulation because the structures within each 10-ns simula-
tion are correlated. We chose the Wilcoxon rank sum test because it is valid for data that are
not normally distributed.
Ending conformations from the ubiquitinated ZAP-70 simulations, shown in S1 Fig, were
selected by choosing from among the last conformations sampled in the 32 production simula-
tions. Specifically, we choose the structure (among those 32 end-points) that differed the most
from the starting ZAP-70 crystal structure based on the F349Cα-D379Cβ distance, which indi-
cates the position of the C-helix. For the active K377-ubiquitinated simulations the ending
structure with the longest distance (14.9 Å) was chosen, and for the inactive K476-ubiquiti-
nated simulations the ending structure with the shortest distance (7.6 Å) was chosen. To create
contact maps, we used ptraj and python scripts to calculate the percent of the snapshots from
our simulations (taken every 100 ps) where each pair of residues was in contact. We plotted
this matrix in R and annotated it with the values for the most populated contacts. We define
residue contacts as a separation of less than 10 Å averaged over the residue. Solvent accessible
surface area of the kinase was calculated using the surf command in cpptraj, which uses the
LCPO method [105]. All protein structure figures were created using VMD [106].
Results
Kinase ubiquitination
As part of a larger study of HIV-host interactions, data were generated to investigate changes
in ubiquitination in response to HIV infection and proteasome inhibition (manuscript in prep-
aration). Ubiquitination sites (indistinguishable from NEDD8 or ISG15 sites) were identified
using ubiquitin remnant immunoaffinity enrichment and quantitative mass spectrometry in
Jurkat and HEK293 cells, both in the presence and absence of HIV infection [107]. The
HEK293 cells were treated with interferon, to activate the expression of known antiviral sub-
strates of ubiquitination and proteasomal degradation, while the Jurkat cells were not. Indeed,
ubiquitination of APOBEC3C and the cellular receptor CD4 (stably transfected in these cells)
were detected in HEK293 experiments responding to the expression of HIV and only in the
presence of a proteasome inhibitor (S2 Fig). As interferon treatment also induces expression of
the ubiquitin-like protein ISG15, which generates an indistinguishable ubiquitin remnant epi-
tope, we used the data from the Jurkat cells, to examine ubiquitination on kinases, including
sensitivity to proteasome inhibition. The Jurkat cells were not interferon treated and thus the
sites identified reflect ubiquitination sites that are not confounded by the possibility of being
ISG15 modifications. This is true even in the HIV infected Jurkat cells since HIV prevents the
activation of interferon stimulated genes by suppressing IRF3 activity [108]. This was verified
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by checking the abundance of ISG15 and proteins known to be induced by interferon, none of
which increased significantly with HIV infection (S1 Dataset). A total of 432 sites were identi-
fied on 132 protein kinases in the Jurkat cell studies (Fig 1). Combining this proteomics data
with those in the PTMfunc database [60], we found that 201 human protein kinases are ubiqui-
tinated at one or more sites, with a total of 845 ubiquitination sites; 107 of these ubiquitin mod-
ifications are proteasome sensitive, and 103 are proteasome insensitive (the proteasome
sensitivity of the remaining sites is unknown). All 103 of the proteasome insensitive ubiquitina-
tion sites were ubiquitinated even in the absence of HIV infection, indicating that they do not
result from nonspecific ubiquitination caused by infection. The frequency of HIV dependence
for ubiquitination sites is reported in supporting information (S2 Table). The 103 proteasome
insensitive ubiquitination sites are unlikely to be associated with degradation by the protea-
some, and may serve another function such as regulation of kinase activity. A full list of all ubi-
quitination sites is provided in the supporting information (S2 Dataset).
We found that most ubiquitin modifications occur on a folded domain (Table 1), in contrast
to phosphorylation sites, which are much more likely to be located in unstructured regions
(Table 1). This difference is statistically significant (p-value< 2.2x10-16 with prop.test) and has
been observed in studies of global ubiquitination [60,62–64], but the underlying reason is not
clear. One possible explanation is that the E3 ligase requires a structured domain for ubiquitin
attachment, whereas kinases require the segment around the phosphorylation site to be in an
extended conformation. Many of the phosphorylation sites located in unstructured regions are
not believed to be functional [60,109,110]. Since most ubiquitin modifications are attached to a
structured region of the kinase, we speculate that those that are proteasome insensitive may
regulate the kinase by affecting the stability, flexibility, or conformation of that structured
region.
Fig 2 maps all of the proteasome-sensitive and proteasome-insensitive ubiquitin modifica-
tions observed in kinase domains onto the protein kinase A (PKA) structure. Ubiquitin modifi-
cations occur on essentially all solvent exposed regions of the kinase domain, but are enriched
on the region of the N-lobe opposite the C-helix and near the glycine loop, at the N-terminal
end of the activation loop, and on the region of the C-lobe distal to the substrate pocket (Fig 2).
These data are consistent with another study that found the glycine-rich loop and the region
N-terminal to the activation loop of kinases to be enriched in ubiquitination sites [61]. Both
proteasome-sensitive and proteasome-insensitive modifications are concentrated in these
Fig 1. Flowchart of proteomics data analysis.
doi:10.1371/journal.pcbi.1004898.g001
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functionally important regions, but certain residues are more commonly associated with pro-
teasome-insensitive ubiquitination. In particular there are residues associated with protea-
some-insensitive ubiquitination on the N-terminal side of the glycine-rich loop, on the N-
terminal side of the activation loop (near the DFGmotif), and one on the C-helix itself. Ubiqui-
tination at these sites may cause specific conformational changes that affect kinase activity or
interaction with other proteins.
We also examined whether kinase ubiquitination sites are conserved across different human
kinases. We found that about half of modification sites are common across more than 5 of the
206 ubiquitinated kinases, and that the ubiquitinated residue is usually conserved as a lysine
across more than 40 other human kinases (Table 1). As a point of comparison (null hypothe-
sis), if the ubiquitination sites were chosen randomly from all the lysine residues on all the
kinases, the percentage occurring at a conserved residue would be 29%. Instead, we observe
that 80% of ubiquitin modifications occur at a conserved residue, indicating that these residues
are preferred. Wagner et al. also reported that ubiquitinated residues are more conserved than
other lysines, possibly because they tend to be in structured regions [62]. We hypothesized that
proteasome-insensitive sites would be more conserved than those affected by proteasome deg-
radation; however, we did not find any significant differences between their conservation. This
implies that, whether or not ubiquitination is associated with proteasomal degradation, the ubi-
quitin modification tends preferentially to occur at conserved sites, many of which are critical
to kinase structure or function.
We also tested whether other PTMs, such as phosphorylation, co-localize with ubiquitina-
tion sites, and determined that 11% of ubiquitination sites occurred within 4 residues of a phos-
phorylation site on the same protein (Table 1). This fraction is higher than the 3% of collocated
sites that would be found if ubiquitination sites were chosen randomly from among all lysine
residues. Similarly, 3% of ubiquitination sites are located near a residue identified as a func-
tional phosphorylation hot spot (sites where phosphorylation is believed to play a role in
Table 1. Comparison of proteasome-sensitive and proteasome-insensitive ubiquitination and phosphorylation sites across human protein
kinases. We have separated out the data from HEK293 cells because they may also include some ISG15 modifications.
Jurkat + PTMfunc On kinase
domain
On any folded
domain
Residue
conserved
Modification
conserved
Near phos.
site
Near phos.
hot spot
% of proteasome-sensitive
ubiquitination sites
52% 78% 87% 55% 11% 7%
% of proteasome-insensitive
ubiquitination sites
42% 79% 81% 50% 17% 5%
% of all ubiquitination sites 47% 72% 80% 48% 11% 3%
% of phosphorylation sites 17% 28% 59% 44% NA NA
HEK293 On kinase
domain
On any folded
domain
Residue
conserved
Modification
conserved
Near phos.
site
Near phos.
hot spot
% of proteasome-sensitive
ubiquitination sites
*56% *80% 79% 44% 12% 4%
% of proteasome-insensitive
ubiquitination sites
*36% *60% 79% 33% 15% 0%
% of all ubiquitination sites 46% 68% 79% 39% 12% 2%
* indicates a significant difference between the proteasome-sensitive and proteasome-insensitive percentages using the function prop.test in R. A
conserved residue is defined as occurring more than 40 times out of 832 kinases, and a conserved modification is defined as occurring more than 5 times.
“Near” is defined as within four residues of the ubiquitinated residue. Phosphorylation hot spots are those sites where phosphorylation is believed to play a
role in function, as determined by the PTMfunc database. We also have data on the effect of HIV expression on ubiquitination, reported in the supporting
information (S2 Table).
doi:10.1371/journal.pcbi.1004898.t001
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Fig 2. All proteasome-sensitive and proteasome-insensitive sites from human kinases. (a) Proteasome-sensitive sites (purple
spheres) mapped onto the PKA structure. Sphere size is proportional to the fraction of ubiquitin modifications that occur at that site. (b)
Proteasome-insensitive sites (pink spheres) mapped onto the PKA structure. Sphere size is proportional to the fraction of ubiquitin
modifications that occur at that site. The C-helix is highlighted by an orange cylinder, K369 on strand β3 of the N-lobe and E386 on the C-
helix (forming the salt bridge that holds the C-helix in place) are shown with orange sticks, and the activation loop is shown in light pink. (c)
Frequency of proteasome-sensitive ubiquitination sites on the kinase domain. (d) Frequency of proteasome-insensitive ubiquitination
sites on the kinase domain. The ubiquitination sites across all kinases are mapped onto the PKA sequence on the x-axis, normalized by
the total density on the kinase domain.
doi:10.1371/journal.pcbi.1004898.g002
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function, as determined by the PTMfunc database) [60], rather than the 0.3% expected from a
random distribution (Table 1). No difference was observed between proteasome-sensitive and
proteasome-insensitive ubiquitination sites with regard to whether they are located near a
phosphorylation site or hot spot.
The kinase with the largest number of proteasome-insensitive ubiquitination sites is ZAP-
70 (Table 2). For this reason, and because its structure, function and regulation are well studied,
we chose ZAP-70 for an initial study of how proteasome-insensitive ubiquitination might affect
kinase structure and dynamics. Fig 3 shows the locations of both proteasome-sensitive and pro-
teasome-insensitive ubiquitination sites on ZAP-70. The first site we chose for modeling ZAP-
70 ubiquitination was K377 (Fig 3), a site close to the C-helix, because the C-helix position is
crucial for kinase activity. We hypothesized that a ubiquitin moiety attached near the C-helix
might disrupt its position and shift the kinase conformation away from the active structure. To
choose a second ZAP-70 ubiquitination site for modeling, we examined the proteasome-insen-
sitive ubiquitination frequency of the various sites across human kinases (Fig 3). The most
common site for proteasome-insensitive ubiquitination is K476 (ZAP-70 numbering), which is
ubiquitinated on 6 kinases: ZAP-70, Lck, MAPK9, MAPK8, MAPK10, and CDK5. The K476
ubiquitination site is not as close to the C-helix and active site as K377, and therefore we
hypothesized that simulations of K476-ubiquitinated ZAP-70 would have a smaller effect on
active site conformation and dynamics, but might still disrupt the active state allosterically.
Both K377 and K476 were ubiquitinated on ZAP-70 in cells not infected with HIV, so these
modifications are likely relevant to normal ZAP-70 kinase regulation.
Table 2. Kinases with the most proteasome-insensitive and proteasome-sensitive ubiquitination sites.
Protein Uniprot
ID
Proteasome-insensitive
sites
Proteasome-sensitive
sites
Sites without proteasome
data
Kinases with the most proteasome-insensitive
ubiquitination sites
Tyrosine-protein kinase ZAP-70 P43403 12 1 6
Tyrosine-protein kinase LCK P06239 7 1 5
Eukaryotic elongation factor 2 kinase O00418 5 0 1
Serine/threonine-protein kinase PAK 2 Q13177 5 0 2
Serine/threonine-protein kinase PAK 3 O75914 4 0 0
Protein kinase C alpha type P17252 3 0 5
Glycogen synthase kinase-3 alpha P49840 3 0 0
Protein kinase C delta type Q05655 3 1 3
Kinases with the most proteasome-sensitive
ubiquitination sites
Cyclin-dependent kinase 1 P06493 0 11 8
Aurora kinase B Q96GD4 0 6 8
Cyclin-dependent kinase 2 P24941 0 6 8
Cyclin-dependent kinase 6 Q00534 1 5 7
Tyrosine-protein kinase ITK/TSK Q08881 0 5 11
Beta-adrenergic receptor kinase 1 P25098 0 4 6
Dual specificity mitogen-activated protein kinase
kinase 2
P36507 0 3 8
Maternal embryonic leucine zipper kinase Q14680 1 3 11
Serine/threonine-protein kinase TBK1 Q9UHD2 0 3 5
Integrin-linked protein kinase Q13418 2 3 6
doi:10.1371/journal.pcbi.1004898.t002
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ZAP-70 MD simulations
We conducted simulations of ZAP-70 starting from the active and inactive-state crystal struc-
tures with a ubiquitin attached at K377 or K476. K377 is near the N-terminal end of the C-
helix (Fig 4(a)), and K476 lies on the opposite side of the N-lobe from the C-helix, near the
hinge region (Fig 4(d)). In all simulations of ubiquitinated ZAP-70, we attached only a single
ubiquitin molecule, as this is the minimal possible modification. The proteomics data does not
determine the number of ubiquitin molecules or, in the case of polyubiquitination, the attach-
ment residue. Since these modifications were proteasome insensitive, they are most likely to be
K63-linked or monoubiquitinated. We acknowledge that K63-linked polyubiquitination may
have different effects from monoubiquitination, but we anticipate that there may be common-
alities, especially since K63-linked polyubiquitin chains are extended, leaving only the proximal
ubiquitin domain to interact with the target protein. As a practical matter, simulating a polyu-
biquitin attachment would also greatly increase the computational expense. For all ZAP-70
simulations we used a construct that was not phosphorylated at Y493 on the activation loop.
The available crystal structures did not include phosphorylation at Y493, and we did not want
our simulations to be complicated by the effects of two modifications away from the crystal
structure. Also, although ZAP-70 must be phosphorylated at Y493 to be fully active, there is no
Fig 3. ZAP-70 ubiquitination. (a) ZAP-70 kinase domain ubiquitination sites. Proteasome-insensitive sites are shown
in yellow, proteasome-sensitive sites and those where proteasome sensitivity is unknown are shown in red. K377 and
K476 are labeled. (b) Most common proteasome-insensitive kinase ubiquitination sites mapped onto the ZAP-70 kinase
structure. The color indicates howmany kinases are ubiquitinated at this site (light blue = 2, grey blue = 3, dark blue = 4,
mauve = 6). Not all of the sites are ubiquitinated on ZAP-70, but the most common site, K476, is. In both figures the C-
helix is represented with an orange cylinder, K369 on strand β3 of the N-lobe and E386 on the C-helix (forming the salt
bridge that holds the C-helix in place) are shown with orange sticks, and the activation loop is shown in pink.
doi:10.1371/journal.pcbi.1004898.g003
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data to indicate whether ZAP-70 ubiquitination occurs prior to or following phosphorylation,
so a ubiquitinated but unphosphorylated ZAP-70 may be relevant in vivo.
In our simulations, the ubiquitin domain interacted only transiently with the ZAP-70 kinase
domain and sampled many different relative orientations (Fig 4), demonstrating that the start-
ing position of the ubiquitin molecule was not important. The range of orientations sampled
by ubiquitin attached at K476 is more restricted than those sampled by ubiquitin attached at
Fig 4. Ubiquitin attachment and sampling. The starting structure for simulations of the active ZAP-70 kinase ubiquitinated at K377 (a) and K476 (d).
The C-helix is shown in orange and the ubiquitin molecule is shown in cyan. The C-terminal β-strand of ubiquitin is highlighted in purple. The diversity
of orientations that the ubiquitin moiety samples, starting from the K377-ubiqutiinated active (b) and inactive (c) structures and K476-ubiquitinated
active (e) and inactive (f) structures is summarized by showing only the orientation of the C-terminal β-strand (purple) relative to the kinase, for
snapshots separated by 1 ns.
doi:10.1371/journal.pcbi.1004898.g004
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K377, probably because K476 is surrounded by other parts of the kinase structure that interfere
sterically with the ubiquitin motion.
K377 and K476 ubiquitination have opposite effects on the kinase conformation. We
performed molecular dynamics on the ZAP-70 kinase domain ubiquitinated at either K377 or
K476, as well as the unmodified control. For each ubiquitination site we performed simulations
starting from the ZAP-70 “active” structure, and starting from the “inactive” structure (see
Methods) for a total of 320 ns of simulations for each construct.
The most striking differences between the ubiquitinated and control simulations of ZAP-70
occurred at the C-helix, which is critical for kinase activity. In the active structure, a salt bridge
between K369 on strand β3 of the N-lobe and E386 on the C-helix holds the C-helix in place,
while in the inactive structure its N-terminal end swings out from the rest of the N-lobe and
rotates [75,76]. We measured this difference using a distance between a backbone atom on the
glycine-rich loop (F349) and the Cβ atom of D379 on the N-terminal end of the C-helix to
indicate how close the C-helix is to the rest of the N-lobe and how much it is rotated (Fig 5). In
the control simulations starting from the active structure, the C-helix remains close to the N-
lobe. Ubiquitination of the active-state structure at K377 (but not at K476) causes the C-helix
to move away from the rest of the N-lobe, disrupting the conformation of the C-helix necessary
for kinase activity (Fig 5). The difference in mean C-helix position between the control active
and K377-ubiquitinated active simulations is significant according to the Wilcoxon rank sum
test, with a p-value of 1.4x10-10 (all p-values comparing modified construct simulations to the
control simulation are given in the supporting information S3 and S4 Tables). In the inactive
control simulations the C-helix remains farther away from the rest of the kinase structure, and
this distance is even slightly increased with ubiquitination at K377 (Fig 5). However, when the
inactive structure is ubiquitinated at K476, the C-helix moves closer to the N-lobe (Wilcoxon
rank sum test p-value = 3.1x10-14 compared to inactive control), approaching a position similar
to that in the active state (Fig 5). Our simulations indicate that ubiquitination at two distinct
sites on the ZAP-70 kinase domain result in opposite effects on kinase conformation and possi-
bly activity.
Ubiquitination of the active ZAP-70 at K377 also causes a significant difference in the sec-
ondary structure of the C-helix (Wilcoxon rank sum test p-value of 2.2x10-6 compared to the
active control), which frequently becomes partially disordered, primarily at the N-terminal side
(Fig 6). This was unexpected, because the C-helix shows the same secondary structure in both
the active and inactive crystal structures. The unmodified ZAP-70 C-helix maintains at least 10
residues in a structured conformation in more than 80% of the simulated ensemble, as does the
K476-ubiquitinated C-helix starting from the active state. Only ubiquitination at K377 leads to a
significant decrease in C-helix structure from the active structure, with just 51% of the simulated
ensemble maintaining 10 or more helical residues. In the control simulations starting from the
inactive state, however, the highly solvent exposed C-helix partially and transiently unfolds,
sometimes retaining only 2 residues in a helical secondary structure (Fig 6). Only 42% of the
inactive-state control ensemble maintains 10 or more helical residues. The K377-ubiquitnated
inactive-state simulations resulted in ensembles with an even more disordered C-helix (only
32% with 10 or more residues ordered). However, K476-ubiquitination of the inactive-state
ZAP-70 resulted in a slight shift toward more ordered C-helix conformations, with 55% of the
ensemble maintaining at least 10 helical residues. These differences are not statistically signifi-
cant, but nonetheless are consistent with the trend of K476-ubiquitination shifting the ZAP-70
inactive-state C-helix more toward the active state. Interestingly, these changes in C-helix struc-
ture all occur without breaking or forming the salt bridge between the C-helix and N-lobe.
It has also been noted that, in the inactive structure, the ZAP-70 N-lobe closes over the C-
lobe, shutting the active site [75,76]. To quantify this conformational change we measure the
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distance between the backbone of the glycine-rich loop on the N-lobe and the C-terminal end
of the activation loop on the C-lobe. In the inactive crystal structure this distance is only about
3 Å shorter than in the active-state crystal structure, but in the inactive simulations the lobes
close together by another 4 Å (Fig 7). In the active simulations they remain open to facilitate
substrate binding. Fig 7 shows that the groove between the N- and C-lobes closes more in the
K377-ubiquitinated simulations than in the control simulations of the active state, with a Wil-
coxon rank sum test p-value of 7.1x10-3. Starting from the inactive structure, ubiquitination at
K476 or K377 leads to a substrate-binding groove that remains more open than the control
(K476 p-value = 1.1x10-5, K377 p-value = 6.3x10-11 both using the Wilcoxon rank sum test and
comparing to the inactive control). While the K476-ubiquitinated structure sampled a C-helix
conformation closer to the active structure as well as sampling a more open binding groove,
the open binding groove was the only large conformational difference for K377-ubiquitinated
ZAP-70 starting from the inactive state. Overall, our simulations suggest that an addition of
Fig 5. Ubiquitination affects ZAP-70 C-helix position.Histograms of the distance between the F349 Cα atom and the D379 Cβ atom during three sets of
ZAP-70 simulations; control simulations, K377-monoubiquitinated, and K476-monoubiquitinated, both started from the active state structure (left) and the
inactive, autoinhibited structure (right). The vertical dashed black lines indicate the distance observed in the starting crystal structure, while the dotted
colored lines indicate the median value for each histogram. The histogram is created from combining all structures sampled in each of the 32 independent
simulations with snapshots every picosecond. In the center, residues F349 and D379 are shown as spheres on the overlaid ZAP-70 active (green) and
inactive (red) crystal structures.
doi:10.1371/journal.pcbi.1004898.g005
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ubiquitin to ZAP-70 at K476 has the opposite effect of ubiquitination at K377, stabilizing the
kinase active conformation rather than disrupting it.
It is possible that on a timescale longer than that of our MD simulations, the conformational
change induced by ubiquitination of the active structure at K377 would become more pro-
nounced and that the K377-ubiquitinated ZAP-70 would adopt the same conformational
ensemble as the inactive kinase. This would probably require that the K369-E386 salt bridge be
broken so that the C-helix could move farther away from the rest of the N-lobe. Alternatively,
ubiquitination at K377 may not fully disrupt the ZAP-70 active state structure, but merely
destabilize it. Either way, our simulations clearly lead to the hypothesis that ubiquitination of
ZAP-70 could negatively affect kinase activity through a conformational change, involving
both the C-helix and the orientations of the N- and C-terminal kinase lobes. We also observe
Fig 6. Ubiquitination affects ZAP-70 C-helix order.Histograms of the number of residues in the C-helix (380–393) that retain the helical conformation,
using the DSSP definition, during three sets of ZAP-70 simulations; control simulations, K377-monoubiquitinated, and K476-monoubiquitinated, both
started from the active state structure (left) and the inactive, autoinhibited structure (right). The vertical dashed black lines indicate the number of helical
residues observed in the starting crystal structure, while the dotted colored lines indicate the median value for each histogram. The histogram is created
from combining all structures sampled in each of the 32 independent simulations with snapshots every picosecond. In the center, the C-helix is highlighted
on the ZAP-70 active crystal structure (green) and an overlaid structure from the inactive conformation simulations (red) where the C-helix is mostly
unraveled (only 6 residues have helical secondary structure).
doi:10.1371/journal.pcbi.1004898.g006
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that K476-ubiquitination stabilizes the ZAP-70 active structure, potentially improving kinase
activity.
The conformational changes are particular to ubiquitination. To test whether other
types of modifications to K377 would result in the same effect, we ran simulations with acetyla-
tion instead of ubiquitination. Ubiquitination neutralizes the lysine residue where it is attached,
and if the affect on conformation were purely due to electrostatic interactions, we might see a
similar outcome with an acetylated lysine. As shown in Fig 8, acetylation has no effect on C-
helix position in the case of K377-acetylation starting from the active structure. For K476-acet-
ylation starting from the inactive structure, the C-helix moves slightly farther away from the
rest of the kinase domain, which is opposite to the effect of K476-ubiquitination. We also ran
simulations starting from the active structure with an Immunoglobulin (Ig) domain attached
at K377 instead of ubiquitin (Fig 9). This domain is similar to ubiquitin in terms of size and β-
sheet content, and has a similar number of positively and negatively charged residues. We
Fig 7. Ubiquitination affects ZAP-70 groove closure.Histograms of the distance between the N348 Cα atom and theW501 Cα atom during three sets of
ZAP-70 simulations; control simulations, K377-monoubiquitinated, and K476-monoubiquitinated, both started from the active state structure (left) and the
inactive, autoinhibited structure (right). The vertical dashed black lines indicate the distance observed in the starting crystal structure, while the dotted
colored lines indicate the median value for each histogram. The histogram is created from combining all structures sampled in each of the 32 independent
simulations with snapshots every picosecond. In the center, residues N348 andW501 are shown as spheres on the overlaid ZAP-70 active (green) and
inactive (red) crystal structures.
doi:10.1371/journal.pcbi.1004898.g007
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anticipated that the conformational effect of ubiquitination at K377 would not be sequence
specific and that the Ig domain would also disrupt the active conformation of the ZAP-70 C-
helix. In fact, the Ig domain does not have the same effect as ubiquitin, as shown in Fig 8. The
Ig domain attached at K377, in the same way as ubiquitin, does not show any differences from
Fig 8. Acetylation and Ig domain attachment do not affect ZAP-70 C-helix position.Histograms of the distance between the F349 Cα atom and the
D379 Cβ atom during ZAP-70 control simulations, K377-monoubiquitinated simulations, K377-acetylated simulations, and simulations with an Ig domain
attached at K377, all started from the active state structure (left), as well as control, K476-monoubiquitinated, and K476-acetylated simulations started from
the inactive, autoinhibited structure (right). The vertical dashed black lines indicate the distance observed in the starting crystal structure, while the dotted
colored lines indicate the median value for each histogram. The histogram is created from combining all structures sampled in each of the 32 independent
simulations with snapshots every picosecond. In the center, residues F349 and D379 are shown as spheres on the overlaid ZAP-70 active (green) and
inactive (red) crystal structures.
doi:10.1371/journal.pcbi.1004898.g008
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the control simulations, therefore the disruptive effect of ZAP-70 K377-ubiquitination appears
to be specific to the ubiquitin sequence or fold. Effects of acetylation and Ig domain attachment
on other metrics are given in the supporting information (S3 and S4 Figs).
Discussion
We find that many of the ubiquitination sites on human kinases are proteasome insensitive,
and therefore likely not associated with protein degradation. We hypothesize that some of
these proteasome insensitive ubiquitin modifications influence the conformation of the mod-
ified protein. A simple way for ubiquitination to affect the structure of a folded protein is to
shift the equilibrium populations of two alternate states. For protein kinases, the active con-
formation is often in equilibrium with an inactive state. There are several important struc-
tural elements that must be in place for kinase activity, including the N-lobe catalytic lysine,
the C-helix, and the substrate binding groove [48,111]. Many different inactive conforma-
tions are possible, since any disruption of the active structure will decrease function. Often,
as is true for ZAP-70, the C-helix is a major site of kinase regulation [48,74]. In the crystal
structure of the autoinhibited form of ZAP-70, the C-helix is swung out from the active con-
formation, but our simulations provide a more detailed picture, revealing that the C-helix is
also less structured and more flexible in the inactive state. Partial unfolding of a kinase C-
helix has also been observed in simulations of the epidermal growth factor receptor in the
inactive state [112]. Ubiquitination could regulate kinase activity by affecting the conforma-
tion of this key helix.
Fig 9. Ig domain sampling. (a) The starting structure for simulations of the active ZAP-70 kinase with an Ig domain
attached at K377. The C-helix is shown in orange and the Ig domain molecule is shown in green. The C-terminal β-strand
of the Ig domain is highlighted in purple. (b) The diversity of orientations that the Ig domain samples, starting from the
K377 active structure with Ig domain attached, is summarized by showing only the orientation of the C-terminal β-strand
(purple) relative to the kinase, for snapshots separated by 1 ns.
doi:10.1371/journal.pcbi.1004898.g009
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Ubiquitin is a site-specific kinase regulator
On the kinase domain, we observe that the glycine-rich loop area and the region N-terminal to
the activation loop are preferentially ubiquitinated, as did Swaney et al. [61]. Phosphorylation
hot spots also cluster to the activation loop and the glycine-rich loop, which are key regions for
kinase regulation [60]. Ubiquitination at regions of the kinase structure associated with confor-
mational regulation indicates that ubiquitin attachment could directly modulate kinase activity
(whether or not this is the primary role of the ubiquitination). We expect only proteasome
insensitive ubiquitination to be responsible for conformational regulation, however both pro-
teasome sensitive and insensitive ubiquitination are enriched in these regions, as well as at con-
served lysine residues and near phosphorylation hot spots, as reported previously for other
proteins [58,61]. Although proteasome sensitive ubiquitination leads to degradation, these ubi-
quitin modifications may still be site-specific because proteases degrade substrates by unfolding
them starting at the site of ubiquitination [113]. Adding a layer of complexity, the same site
can be associated with proteasomal degradation on one kinase, and not on a different kinase or
under different cellular conditions.
There are also specific sites that are particularly associated with proteasome-insensitive ubi-
quitination. The conservation of these ubiquitination sites, like ZAP-70 K476, across kinases
indicates that ubiquitination plays an important functional role at these sites, which is likely
not related to proteasomal degradation. We also found that most ubiquitinated kinases had
multiple sites of ubiquitination, as was previously observed in global ubiquitination studies [8].
For some of these kinases, such as ZAP-70, several of these sites are not associated with protea-
somal degradation. In fact, these different ubiquitination sites may differentially affect confor-
mation of the same protein. Our MD studies of two different ubiquitinated constructs of the
ZAP-70 kinase domain indicate that attachment of a single ubiquitin molecule to a surface
lysine modifies the kinase structure and dynamics in a site specific manner. Ubiquitination at
K377, near the C-helix, causes ZAP-70 to adopt conformations closer to the inactive state,
while ubiquitination at K476, near the hinge region, results in a conformational ensemble more
similar to the active state. On the basis of these simulations, we hypothesize that ubiquitination
at different sites may differentially modulate kinase activity and/or interactions. Since K476 is a
conserved ubiquitination site on kinases, it is also possible that other kinases will undergo simi-
lar conformational changes to ZAP-70 when ubiquitinated at this site.
Importantly, we recognize that incomplete sampling is a limitation of our MD results. Our
simulations starting from the active and inactive ZAP-70 crystal structures are fundamentally
the same since the autoinhibitory domains from the inactive crystal structure are removed in
our simulations. The differences in ZAP-70 conformation that we observe are a result of differ-
ent starting structures. The K369-E386 salt bridge that holds the C-helix in the active state is
not broken in our active structure simulations and not formed in our inactive structure simula-
tions. If the sampling were increased, we would observe these rare events and the ensembles
sampled starting from the active and inactive states would converge. Because we have run
many independent short simulations, we also do not sample motions that occur on long time-
scales. We ran a single long simulation for each of four ZAP-70 constructs (active control,
active K377-ubiquitinated, inactive control, and inactive K476-ubiquitinated) to compare to
our data combined from many short simulations (S5 and S6 Figs). In these long simulations we
also do not observe breaking or forming of the K369-E386 salt bridge, but we do observe more
opening of the substrate binding groove in the K476-ubiquitinated simulations starting from
the inactive structure, indicating that this may be a motion that occurs on a longer timescale
(S5 Fig). Overall we see that the data from a single long simulation has a narrower distribution
than the data from many short simulations (S5 and S6 Figs), since the different time points
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from a single simulation are correlated. We therefore prefer many short simulations to a single
long simulation for assessing the effects of ubiquitination on ZAP-70. Given total simulation
times on the order of 100 ns, these short simulations provide better sampling of the true con-
formational distribution for ubiquitinated ZAP-70.
Having simulated only the kinase domain, we also cannot directly infer what the effects of
ubiquitination are on the full-length ZAP-70. However, our simulations may be a reasonable
approximation of the ZAP-70 kinase domain following TCR complex binding and the release
of the SH2 domains from the kinase domain. After this release, the SH2 domains only interact
with the kinase domain through a flexible linker, and the kinase domain is catalytically active
when the SH2 domains are cleaved [81]. Another limitation of this study is the presence of
only one ubiquitination molecule in the ZAP-70 simulations. In vivo, a polyubiquitin chain
may be attached; however, we cannot distinguish the number of ubiquitin molecules or the
linkage residue for polyubiquitination. Given this ambiguity, we chose to simulate monoubi-
quitinated ZAP-70, which is the simplest possible construct.
Ubiquitin is a unique post-translational modification
Our simulations indicate that ubiquitination has the potential to regulate kinase structure and
dynamics, leading us to compare its effects to other PTMs like phosphorylation. We found that
kinase ubiquitination occurs more frequently on a folded domain than on unstructured linkers
or tails, unlike phosphorylation, which occurs more in unstructured regions. Similar trends
were reported by Wagner et al. and Hagai et al. in studies of ubiquitination across all protein
families [62,63], and Duttler et al. found that ubiquitination of nascent protein chains also is
not enriched in regions of intrinsic disorder [64]. Several studies have noted that within these
structured domains, ubiquitination tends to occur on loops or flexible regions rather than heli-
ces, or, in particular, β-sheets [114–116]. Beltrao et al. also found that ~75% of phosphorylation
sites, 40% of acetylation sites, and 45% of ubiquitination sites occur outside PFAM globular
domains, after looking at all proteins in the PTMfunc database [60]. Focusing only on kinases,
we found that ubiquitination occurs outside folded domains even more rarely, only ~30%.
While phosphorylation on linkers and tails allows these regions of kinases to become ordered
or disordered, affecting kinase conformation, ubiquitination likely regulates kinases by a differ-
ent mechanism. Acetylation, like ubiquitination, occurs in structured regions, and in fact one
of its roles may be to protect against ubiquitination. Wagner et al. found that 30% of acetylated
lysines are also ubiquitinated, and these residues show a lower dependence on proteasome
inhibitor [62]. However, while acetylated lysines show an enrichment in basic residues in the
flanking sequence, flanking regions of ubiquitination sites are enriched in acidic aspartate resi-
dues [115,116]. Both acetylation and ubiquitination sites tend to be near hydrophobic residues,
which may indicate that they are more buried and modifications at these sites could result in
large conformational changes [116]. Based on the structural preferences of ubiquitination for
folded domains of kinases, we expect it to play a different role in kinase regulation than
phosphorylation.
Both phosphorylation and acetylation primarily affect protein conformation by perturbing
the energy landscape electrostatically. For example, simulations of phosphorylated kinases
reveal how the addition of a negatively charged phosphate group on the activation loop can sta-
bilize a protein conformation that is aligned for kinase activity, or in some cases directly stabi-
lize the correct orientation of the substrate side chain [65]. The few molecular dynamics
studies of lysine acetylation suggest that, analogous to phosphorylation, its primary effect may
be driven by electrostatics, i.e., neutralization of the positive charge on the Lys side chain
[70,71]. Like acetylation, ubiquitination neutralizes the positive charge on the lysine residue.
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However, in our simulations acetylation does not have the same affect as ubiquitination on
conformation at either ZAP-70 site. Unlike acetylation and phosphorylation, the effect of ubi-
quitination on the kinase energy landscape is not primarily electrostatic. Ubiquitin is much
larger than the acetyl group and this bulky group may have significant entropic consequences
including solvent effects.
Allosteric effects of ubiquitination on kinase conformation
We observe that ubiquitination at residues that are not critical to kinase activity may allosteri-
cally regulate the kinase by changing its overall conformation. In the case of ZAP-70 ubiquiti-
nation, this appears to be mediated by the position and structure of the C-helix and possibly
the peptide-binding groove. Previous work by McClendon et al. used MD simulations of PKA
and the mutual information between residues to reveal a network of correlated motions that
could mediate long-distance allosteric coupling in kinases [117]. There are several ways that
ubiquitin may be perturbing these correlated motions to alter kinase conformation. Our simu-
lations of ubiquitinated ZAP-70 show that the ubiquitin moiety is attached flexibly to the
kinase and samples many orientations (Fig 4). This supports earlier observations of multiple
ubiquitin orientations for the ubiquitinated Ras protein from NMR and computational models
[24], and indicates that the effects of ubiquitin may be entropic.
Molecular dynamics simulations of ubiquitinated proteins by Hagai and Levy have charac-
terized the effect of ubiquitination on thermodynamic stability of a protein [118]. They observe
a decrease in protein stability upon ubiquitination that they attribute to entropic stabilization
of the unfolded state of the protein. They conclude that destabilization, along with local unfold-
ing at the ubiquitination site, may facilitate protein unfolding prior to degradation. In our
K377-ubiquitinated ZAP-70 simulations, we observe partial unfolding of the C-helix, which
also moves away from the rest of the N-lobe (Figs 5 & 6). Entropic stabilization of the locally
unfolded state may explain this partial C-helix unfolding.
We were surprised to observe that ubiquitin attachment at K377 leads to C-helix disruption,
while the attachment of the similarly sized Ig domain at K377 (Fig 9) does not significantly dis-
rupt the C-helix (Fig 8). This indicates that the specific sequence or shape of the ubiquitin mol-
ecule plays a role in disrupting the ZAP-70 C-helix structure. Fig 10 shows ZAP-70 contacts
with both the ubiquitin and Ig-domain molecules when attached at K377. The contacts with
ubiquitin are present in much more of the simulated ensemble than the contacts with the Ig
domain. Some of the ubiquitin contacts likely result from forming hydrogen bonds, but ion
pairs also transiently form between ubiquitin and the kinase. For K377-ubiquitinated ZAP-70,
there are contacts between E376 and both R72 and R42 on ubiquitin, especially in the inactive
state simulations. Interestingly, R72 and R42 are near the ubiquitin “hydrophobic patch” that
is the site of recognition by ubiquitin binding domains [119], although the key hydrophobic
patch residue, I44, does not contact the kinase. In the simulations with the Ig domain attached
at residue 377, we do not observe any ion pair interactions between the two proteins, nor are
there significant hydrophobic contacts formed. This may explain why no conformational
change occurs in simulations with the Ig domain attached to ZAP-70.
Electrostatic interactions, like what we observe between ZAP-70 and ubiquitin, are also
present in the ubiquitinated structure of PCNA. K164-ubiquitinated PCNA adopts a different
conformation from SUMOylated PCNA due to specific electrostatic interactions with ubiquitin
R42, K48, E51, D58, and D39 [31]. In the SUMOylated structure, however there is electrostatic
repulsion between two negatively charged surfaces, resulting in an extended conformation with
few contacts [31], as we observe with Ig domain. Like our simulations, the studies of PCNA
ubiquitination and SUMOylation only included one ubiquitin or SUMOmolecule. Since
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Fig 10. ZAP-70 contacts with ubiquitin or the Ig domain.Contact maps showing the ZAP-70 sequence vs. the ubiquitin sequence for
K377 ubiquitination starting from the active-state structure and inactive-state structure, and a contact map showing the ZAP-70 sequence
vs. the Ig domain sequence for K377 Ig domain attachment starting from the active-state structure. The darkness of the pixel indicates the
percent of snapshots from the simulation where these two residues are in contact. A contact is defined as a distance of less than 10 Å
between residue centers of mass. In the structures shown above, the residues that are frequently involved in contacts are colored and
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ubiquitin moieties that are part of a polyubiquitin chain are known to interact with each other,
there could be competition for the interactions with ZAP-70 if it were polyubiquitinated. How-
ever, the conformational effects might also be exaggerated with the presence of multiple ubi-
quitin moieties.
Specific interactions between ubiquitin and ZAP-70 in the K476-ubiquitinated simulations
are shown in Fig 11. In the K476-ubiquitinated simulations, both E415 and D365 on ZAP-70
interact with R74 on ubiquitin, and ZAP-70 R594 contacts ubiquitin E51. The ZAP-70 C-ter-
minal F614 also interacts with hydrophobic ubiquitin residues. However, while K377-ubiquiti-
nated ZAP-70 ionic interactions could directly perturb the C-helix linker, a more complex
mechanism is likely at play for K476 ubiquitination, since ubiquitin does not directly contact
the C-helix in this construct. Hagai and Levy note that the thermodynamic effects of ubiquiti-
nation vary depending on the attachment site [118]. Atomistic MD simulations also show that
ubiquitination of Ubc7, an E2 enzyme, decreases the flexibility of certain regions of Ubc7
although there were no specific direct interactions between ubiquitin and the E2 [120]. We
observe similar stabilization of the C-helix with ubiquitination at K476, also in the absence of
any stable interactions between ubiquitin and ZAP-70. The Ubc7 simulations also show that
the strongest effect occurred with K48-linked tetraubiquitination at known sites of degradative
ubiquitination [120], indicating that polyubiquitination could have an even larger effect on
ZAP-70 conformation than monoubiquitination.
The K476 ubiquitination site is farther from the C-helix than K377, yet somehow the pres-
ence of ubiquitin shifts the conformational equilibrium toward an active kinase structure with
a stable folded C-helix that remains close to the rest of the N-lobe. Coupling between the acti-
vation loop and the C-helix can allow communication between the active site and the back of
the kinase, where K476 is located [48]; however, we could not find any specific residues
between K476 and the active site that were perturbed by the presence of ubiquitin. Another
possible mechanism involves the bulky ubiquitin modifying the interaction between the pro-
tein and solvent. In the simulations of unmodified ZAP-70 as well as all K377-ubiquitinated
simulations, the solvent accessible surface area of the kinase domain remains similar (Fig 12).
In contrast, K476-ubiquitination modifies the exposed surface area, decreasing it slightly when
starting from the active state, and increasing it significantly when starting from the inactive
state (Fig 12). These results imply a net decrease in solvent accessible surface area from the
inactive to active state when K476 is ubiquitinated. Thus, ubiquitin attachment may indirectly
impact protein structure and dynamics by modulating solvation, which could involve both
enthalpic interactions between water and the protein, and increases in water entropy accompa-
nying decreased solvent exposure. In the case of polyubiquitination, the attached moiety would
be even larger, possibly increasing or modifying the solvent-mediated effects of ubiquitination
on conformation.
Our study suggests that ubiquitination may regulate kinases in a manner unrelated to degra-
dation, and that this regulation could result from site-specific changes in conformational
dynamics. Simulations of ZAP-70 predict that ubiquitination at K377 or K476 could respec-
tively reduce or increase kinase activity. Ubiquitination may also affect conformation in other
protein families, and future work should explore the role of ubiquitin in non-degradative sig-
naling, including further investigation of the biophysical effects of ubiquitination.
labeled, both on ZAP-70 and the ubiquitin and Ig domain moieties. The attached protein is shown in white, while the ZAP-70 structure is
shown in dark gray. The corresponding colors are shown next to the axes on the contact maps. The contact regions with the highest
frequency are also labeled with their frequencies on the contact maps. The color of these labels corresponds to the color of the ubiquitin or
Ig domain residues involved.
doi:10.1371/journal.pcbi.1004898.g010
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Fig 11. Ubiquitin-ZAP-70 contacts.Contact maps showing the ZAP-70 sequence vs. the ubiquitin sequence for K377 ubiquitination starting from
the active-state structure and inactive-state structure, and K476 ubiquitination starting from the active-state structure and inactive-state structure.
The darkness of the pixel indicates the percent of snapshots from the simulation where these two residues are in contact. A contact is defined as a
distance of less than 10 Å between residue centers of mass. In the ubiquitinated structures shown above, the residues that are frequently involved in
contacts are colored and labeled, both on ubiquitin and ZAP-70. The ubiquitin moiety is shown in white, while the ZAP-70 structure is shown in dark
gray. The corresponding colors are shown next to the axes on the contact maps. The contact regions with the highest frequency are also labeled with
their frequencies on the contact maps. The color of these labels corresponds to the color of the ubiquitin residues involved.
doi:10.1371/journal.pcbi.1004898.g011
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Supporting Information
S1 Table. Details of simulation solvent box for ZAP-70 constructs.
(PDF)
S2 Table. HIV dependence of ubiquitination sites identified in Jurkat and HEK293 cells.
(PDF)
S3 Table. P-value statistics testing the hypothesis that simulation metrics have the same dis-
tribution as the unmodified control simulations started from the same ZAP-70 crystal
structure.
(PDF)
S4 Table. P-value statistics testing the hypothesis that simulation metrics have the same dis-
tribution as the unmodified control simulations started from the same ZAP-70 crystal
Fig 12. ZAP-70 kinase domain solvent accessible surface area.Histogram of the solvent accessible surface area during
the control, K377-ubiquitinaed, and K476-ubiquitinated simulations starting from the active state structure (left) and inactive
structure (right). The vertical dashed black lines indicate the surface area for the starting crystal structure, while the dotted
colored lines indicate the median value for each histogram.
doi:10.1371/journal.pcbi.1004898.g012
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structure. Using the medians of each simulation as the data.
(PDF)
S1 Fig. Ubiquitinated ending structures. Example ending conformation from active
K377-ubiquitinated simulations superimposed on the ZAP-70 active crystal structure (a) and
from inactive K476-ubiquitinated simulations superimposed on the ZAP-70 inactive crystal
structure (b). The crystal structure is shown in grey, C-helix residues are highlighted in green
(a) or red (b), and the ubiquitin molecule is shown in cyan. (a) The F349Cα-D379Cβ dis-
tance = 14.9 Å. (b) The F349Cα-D379Cβ distance = 7.6 Å.
(TIF)
S2 Fig. Known substrates of HIV ubiquitination are detected in HEK293 cells expressing
HIV. The sum of MS1 intensities of all ubiquitinated peptides are plotted for known substrates
of HIV-mediated ubiquitination CD4 (a) and APOBEC3C (b) in response to doxycycline-
induced expression of HIV.
(TIFF)
S3 Fig. Acetylation and Ig domain attachment do not affect ZAP-70 C-helix order.Histo-
grams of the number of residues in the C-helix (380–393) that retain the helical conformation,
using the DSSP definition, during ZAP-70 control simulations, K377-monoubiquitinated sim-
ulations, K377-acetylated simulations, and simulations with the Ig domain attached at K377,
all started from the active state structure (left), as well as control, K476-monoubiquitinated,
and K476-acetylated simulations started from the inactive, autoinhibited structure (right). The
vertical dashed black lines indicate the distance observed in the starting crystal structure, while
the dotted colored lines indicate the median value for each histogram. The histogram is created
from combining all structures sampled in each of the 32 independent simulations with snap-
shots every picosecond. In the center, the C-helix is highlighted on the ZAP-70 active crystal
structure (green) and an overlaid structure from the inactive conformation simulations (red)
where the C-helix is mostly unraveled (only 6 residues have helical secondary structure).
(TIF)
S4 Fig. Acetylation and Ig domain attachment do not affect ZAP-70 groove closure.Histo-
grams of the distance between the N348 Cα atom and theW501 Cα atom during ZAP-70 control
simulations, K377-monoubiquitinated simulations, K377-acetylated simulations, and simula-
tions with the Ig domain attached at K377, all started from the active state structure (left), as well
as control, K476-monoubiquitinated, and K476-acetylated simulations started from the inactive,
autoinhibited structure (right). The vertical dashed black lines indicate the distance observed in
the starting crystal structure, while the dotted colored lines indicate the median value for each
histogram. The histogram is created from combining all structures sampled in each of the 32
independent simulations with snapshots every picosecond. In the center, residues N348 and
W501 are highlighted on the overlaid ZAP-70 active (green) and inactive (red) crystal structures.
(TIF)
S5 Fig. Results of single long simulation started from the active state crystal structure, with
and without ubiquitination at K377.Histograms of the distance between the F349 Cα atom
and the D379 Cβ atom (a), the number of residues in the C-helix (380–393) that retain the heli-
cal conformation, using the DSSP definition (b), and the distance between the N348 Cα atom
and theW501 Cα atom (c). Each of these is plotted for the set of 32 short control simulations,
the single 100-ns control simulation, the set of 32 short K377-ubiquitinated simulations, and
the single 560-ns K377-ubiquitinated simulation. All of these simulations started from the ZAP-
70 active state crystal structure. The vertical dashed black lines indicate the distance observed in
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the starting crystal structure, while the dotted colored lines indicate the median value for each
histogram. The histogram is created by combining all structures sampled in each of the 32 inde-
pendent simulations (or single long simulation) with snapshots every picosecond.
(TIF)
S6 Fig. Results of single long simulation started from the inactive state crystal structure,
with and without ubiquitination at K476.Histograms of the distance between the F349 Cα
atom and the D379 Cβ atom (a), the number of residues in the C-helix (380–393) that retain the
helical conformation, using the DSSP definition (b), and the distance between the N348 Cα
atom and theW501 Cα atom (c). Each of these is plotted for the set of 32 short control simula-
tions, the single 100-ns control simulation, the set of 32 short K476-ubiquitinated simulations,
and the single 560-ns K476-ubiquitinated simulation. All of these simulations started from the
ZAP-70 inactive state crystal structure. The vertical dashed black lines indicate the distance
observed in the starting crystal structure, while the dotted colored lines indicate the median
value for each histogram. The histogram is created by combining all structures sampled in each
of the 32 independent simulations (or single long simulation) with snapshots every picosecond.
(TIF)
S1 Dataset. Protein abundance data from Jurkat cells for ubiquitin, ISG15, NEDD8, several
interferon induced proteins, and BST2, which are known to be degraded upon HIV infec-
tion. Table of protein abundance fold-changes and adjusted p-values as calculated by MSstats
(see Methods) for ubiquitin, ISG15, NEDD8, and select interferon-induced proteins.
(XLSX)
S2 Dataset. All ubiquitination sites from combined Jurkat cell dataset and PTMfunc data-
base. There is a row for each ubiquitination site and the columns tell the name of the protein
ubiquitinated, the residue number of the modification, the corresponding aligned residue on
PKA (if there is one), the corresponding aligned residue on ZAP-70 (if there is one), whether
the site is proteasome dependent or independent (if known), whether the site is on the kinase
domain, whether the site is on any folded protein domain, whether the modification shows any
dependence on HIV infection (if known), whether the abundance of the corresponding peptide
shows any dependence on HIV infection (if known), whether the ubiquitination site is near a
phosphorylation site, whether the ubiquitination site is near a phosphorylation hot spot as des-
ignated by the PTMfunc database, and the source of the modification (Jurkat cell experiment,
PTMfunc database, or both).
(XLSX)
S3 Dataset. Ubiquitination sites from HEK293 cell dataset. There is a row for each ubiquiti-
nation site and the columns tell the name of the protein ubiquitinated, the residue number of
the modification, the corresponding aligned residue on PKA (if there is one), the correspond-
ing aligned residue on ZAP-70 (if there is one), whether the site is proteasome dependent or
independent (if known), whether the site is on the kinase domain, whether the site is on any
folded protein domain, whether the modification shows any dependence on HIV infection (if
known), whether the ubiquitination site is near a phosphorylation site, whether the ubiquitina-
tion site is near a phosphorylation hot spot as designated by the PTMfunc database.
(XLSX)
S4 Dataset. Jurkat cell kinase ubiquitination data. Log2-fold-changes (L2FC) and adjusted
p-values as calculated by MSstats (see Materials and Methods) for ubiquitination sites in Jurkat
cells infected with HIV. UniProt accessions, gene names, descriptions, and modified site posi-
tions are indicated; multiple accessions separated by semi-colons indicate sites for which
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peptide sequences were identical between multiple UnirProt entries. L2FC and adjusted p-val-
ues are indicated for the following comparisons: HIV-infected vs. uninfected cells, HIV-
infected and MG-132-treated vs uninfected and MG-132-treated cells, and uninfected MG-
132-treated and uninfected untreated cells.
(XLS)
S5 Dataset. HEK293 cell kinase ubiquitination data. Log2-fold-changes (L2FC) and adjusted
p-values as calculated by MSstats (see Materials andMethods) for ubiquitination sites in HEK293
cells engineered to express HIV by a tetracycline-responsive promoter. UniProt accessions, gene
names, descriptions, and modified site positions are indicated; multiple accessions separated by
semi-colons indicate sites for which peptide sequences were identical between multiple UnirProt
entries. L2FC and adjusted p-values are indicated for the following comparisons: all doxycycline-
treated vs. all untreated cells (Dox all v Mock all), doxycycline-treatedMG-132-treated vs. doxy-
cycline-treated cells (DoxMG v Dox), doxycycline-treated MG-132-treated vs. MG-132-treated
cells (Dox MG vMock MG), and doxycycline-treated vs. untreated cells (Dox v Mock).
(XLS)
S6 Dataset. ZAP-70 active simulation F349 Cα—D379 Cβ distance file. The distance between
the ZAP-70 F349 Cα atom and the D379 Cβ atom at each picosecond in the simulations is
printed in Angstroms. Data from each of the 32 10-ns simulations is combined into one file.
(BZ2)
S7 Dataset. ZAP-70 inactive simulation F349 Cα—D379 Cβ distance file. The distance
between the ZAP-70 F349 Cα atom and the D379 Cβ atom at each picosecond in the simulations
is printed in Angstroms. Data from each of the 32 10-ns simulations is combined into one file.
(BZ2)
S8 Dataset. ZAP-70 K377-ubiquitinated active simulation F349 Cα—D379 Cβ distance
file. The distance between the ZAP-70 F349 Cα atom and the D379 Cβ atom at each picosec-
ond in the simulations is printed in Angstroms. Data from each of the 32 10-ns simulations is
combined into one file.
(BZ2)
S9 Dataset. ZAP-70 K377-ubiquitinated inactive simulation F349 Cα—D379 Cβ distance
file. The distance between the ZAP-70 F349 Cα atom and the D379 Cβ atom at each picosec-
ond in the simulations is printed in Angstroms. Data from each of the 32 10-ns simulations is
combined into one file.
(BZ2)
S10 Dataset. ZAP-70 K476-ubiquitinated active simulation F349 Cα—D379 Cβ distance
file. The distance between the ZAP-70 F349 Cα atom and the D379 Cβ atom at each picosec-
ond in the simulations is printed in Angstroms. Data from each of the 32 10-ns simulations is
combined into one file.
(BZ2)
S11 Dataset. ZAP-70 K476-ubiquitinated inactive simulation F349 Cα—D379 Cβ distance
file. The distance between the ZAP-70 F349 Cα atom and the D379 Cβ atom at each picosec-
ond in the simulations is printed in Angstroms. Data from each of the 32 10-ns simulations is
combined into one file.
(BZ2)
S12 Dataset. ZAP-70 K377-acetylated active simulation F349 Cα—D379 Cβ distance file.
The distance between the ZAP-70 F349 Cα atom and the D379 Cβ atom at each picosecond in
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the simulations is printed in Angstroms. Data from each of the 32 10-ns simulations is com-
bined into one file.
(BZ2)
S13 Dataset. ZAP-70 K476-acetylated inactive simulation F349 Cα—D379 Cβ distance file.
The distance between the ZAP-70 F349 Cα atom and the D379 Cβ atom at each picosecond in
the simulations is printed in Angstroms. Data from each of the 32 10-ns simulations is com-
bined into one file.
(BZ2)
S14 Dataset. ZAP-70 K377-Ig domain active simulation F349 Cα—D379 Cβ distance file.
The distance between the ZAP-70 F349 Cα atom and the D379 Cβ atom at each picosecond in
the simulations is printed in Angstroms. Data from each of the 32 10-ns simulations is com-
bined into one file.
(BZ2)
S15 Dataset. ZAP-70 100-ns active simulation F349 Cα—D379 Cβ distance file. The dis-
tance between the ZAP-70 F349 Cα atom and the D379 Cβ atom at each picosecond in the sim-
ulations is printed in Angstroms.
(BZ2)
S16 Dataset. ZAP-70 100-ns inactive simulation F349 Cα—D379 Cβ distance file. The dis-
tance between the ZAP-70 F349 Cα atom and the D379 Cβ atom at each picosecond in the sim-
ulations is printed in Angstroms.
(BZ2)
S17 Dataset. ZAP-70 560-ns K377-ubiquitinated active simulation F349 Cα—D379 Cβ dis-
tance file. The distance between the ZAP-70 F349 Cα atom and the D379 Cβ atom at each
picosecond in the simulations is printed in Angstroms.
(BZ2)
S18 Dataset. ZAP-70 560-ns K476-ubiquitinated inactive simulation F349 Cα—D379 Cβ
distance file. The distance between the ZAP-70 F349 Cα atom and the D379 Cβ atom at each
picosecond in the simulations is printed in Angstroms.
(BZ2)
S19 Dataset. ZAP-70 active simulation C-helix secondary structure file. The DSSP second-
ary structure of each ZAP-70 residue at each picosecond in the simulations is printed. Data
from each of the 32 10-ns simulations is combined into one file.
(BZ2)
S20 Dataset. ZAP-70 inactive simulation C-helix secondary structure file. The DSSP sec-
ondary structure of each ZAP-70 residue at each picosecond in the simulations is printed. Data
from each of the 32 10-ns simulations is combined into one file.
(BZ2)
S21 Dataset. ZAP-70 K377-ubiquitinated active simulation C-helix secondary structure
file. The DSSP secondary structure of each ZAP-70 residue at each picosecond in the simula-
tions is printed. Data from each of the 32 10-ns simulations is combined into one file.
(BZ2)
S22 Dataset. ZAP-70 K377-ubiquitinated inactive simulation C-helix secondary structure
file. The DSSP secondary structure of each ZAP-70 residue at each picosecond in the
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simulations is printed. Data from each of the 32 10-ns simulations is combined into one file.
(BZ2)
S23 Dataset. ZAP-70 K476-ubiquitinated active simulation C-helix secondary structure
file. The DSSP secondary structure of each ZAP-70 residue at each picosecond in the simula-
tions is printed. Data from each of the 32 10-ns simulations is combined into one file.
(BZ2)
S24 Dataset. ZAP-70 K476-ubiquitinated inactive simulation C-helix secondary structure
file. The DSSP secondary structure of each ZAP-70 residue at each picosecond in the simula-
tions is printed. Data from each of the 32 10-ns simulations is combined into one file.
(BZ2)
S25 Dataset. ZAP-70 K377-acetylated active simulation C-helix secondary structure file.
The DSSP secondary structure of each ZAP-70 residue at each picosecond in the simulations is
printed. Data from each of the 32 10-ns simulations is combined into one file.
(BZ2)
S26 Dataset. ZAP-70 K476-acetylated inactive simulation C-helix secondary structure file.
The DSSP secondary structure of each ZAP-70 residue at each picosecond in the simulations is
printed. Data from each of the 32 10-ns simulations is combined into one file.
(BZ2)
S27 Dataset. ZAP-70 K377-Ig domain active simulation C-helix secondary structure file.
The DSSP secondary structure of each ZAP-70 residue at each picosecond in the simulations is
printed. Data from each of the 32 10-ns simulations is combined into one file.
(BZ2)
S28 Dataset. ZAP-70 100-ns active simulation C-helix secondary structure file. The DSSP
secondary structure of each ZAP-70 residue at each picosecond in the simulations is printed.
(BZ2)
S29 Dataset. ZAP-70 100-ns inactive simulation C-helix secondary structure file. The DSSP
secondary structure of each ZAP-70 residue at each picosecond in the simulations is printed.
(BZ2)
S30 Dataset. ZAP-70 560-ns K377-ubiquitinated active simulation C-helix secondary struc-
ture file. The DSSP secondary structure of each ZAP-70 residue at each picosecond in the sim-
ulations is printed.
(BZ2)
S31 Dataset. ZAP-70 560-ns K476-ubiquitinated inactive simulation C-helix secondary
structure file. The DSSP secondary structure of each ZAP-70 residue at each picosecond in the
simulations is printed.
(BZ2)
S32 Dataset. ZAP-70 active simulation N348 Cα—W501 Cα distance file. The distance
between the ZAP-70 N348 Cα atom and the W501 Cα atom at each picosecond in the simula-
tions is printed in Angstroms. Data from each of the 32 10-ns simulations is combined into
one file.
(BZ2)
S33 Dataset. ZAP-70 inactive simulation N348 Cα—W501 Cα distance file. The distance
between the ZAP-70 N348 Cα atom and the W501 Cα atom at each picosecond in the
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simulations is printed in Angstroms. Data from each of the 32 10-ns simulations is combined
into one file.
(BZ2)
S34 Dataset. ZAP-70 K377-ubiquitinated active simulation N348 Cα—W501 Cα distance
file. The distance between the ZAP-70 N348 Cα atom and the W501 Cα atom at each picosec-
ond in the simulations is printed in Angstroms. Data from each of the 32 10-ns simulations is
combined into one file.
(BZ2)
S35 Dataset. ZAP-70 K377-ubiquitinated inactive simulation N348 Cα—W501 Cα distance
file. The distance between the ZAP-70 N348 Cα atom and the W501 Cα atom at each picosec-
ond in the simulations is printed in Angstroms. Data from each of the 32 10-ns simulations is
combined into one file.
(BZ2)
S36 Dataset. ZAP-70 K476-ubiquitinated active simulation N348 Cα—W501 Cα distance
file. The distance between the ZAP-70 N348 Cα atom and the W501 Cα atom at each picosec-
ond in the simulations is printed in Angstroms. Data from each of the 32 10-ns simulations is
combined into one file.
(BZ2)
S37 Dataset. ZAP-70 K476-ubiquitinated inactive simulation N348 Cα—W501 Cα distance
file. The distance between the ZAP-70 N348 Cα atom and the W501 Cα atom at each picosec-
ond in the simulations is printed in Angstroms. Data from each of the 32 10-ns simulations is
combined into one file.
(BZ2)
S38 Dataset. ZAP-70 K377-acetylated active simulation N348 Cα—W501 Cα distance file.
The distance between the ZAP-70 N348 Cα atom and the W501 Cα atom at each picosecond
in the simulations is printed in Angstroms. Data from each of the 32 10-ns simulations is com-
bined into one file.
(BZ2)
S39 Dataset. ZAP-70 K476-acetylated inactive simulation N348 Cα—W501 Cα distance
file. The distance between the ZAP-70 N348 Cα atom and the W501 Cα atom at each picosec-
ond in the simulations is printed in Angstroms. Data from each of the 32 10-ns simulations is
combined into one file.
(BZ2)
S40 Dataset. ZAP-70 K377-Ig domain active simulation N348 Cα—W501 Cα distance file.
The distance between the ZAP-70 N348 Cα atom and the W501 Cα atom at each picosecond
in the simulations is printed in Angstroms. Data from each of the 32 10-ns simulations is com-
bined into one file.
(BZ2)
S41 Dataset. ZAP-70 100-ns active simulation N348 Cα—W501 Cα distance file. The dis-
tance between the ZAP-70 N348 Cα atom and the W501 Cα atom at each picosecond in the
simulations is printed in Angstroms.
(BZ2)
S42 Dataset. ZAP-70 100-ns inactive simulation N348 Cα—W501 Cα distance file. The dis-
tance between the ZAP-70 N348 Cα atom and the W501 Cα atom at each picosecond in the
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simulations is printed in Angstroms.
(BZ2)
S43 Dataset. ZAP-70 560-ns K377-ubiquitinated active simulation N348 Cα—W501 Cα
distance file. The distance between the ZAP-70 N348 Cα atom and the W501 Cα atom at each
picosecond in the simulations is printed in Angstroms.
(BZ2)
S44 Dataset. ZAP-70 560-ns K476-ubiquitinated inactive simulation N348 Cα—W501 Cα
distance file. The distance between the ZAP-70 N348 Cα atom and the W501 Cα atom at each
picosecond in the simulations is printed in Angstroms.
(BZ2)
S45 Dataset. ZAP-70 K377-ubiquitinated active simulation kinase-ubiquitin contact
matrix file. The fraction of the simulation snapshots where each pair of residues on ZAP-70
and ubiquitin are within 10 Angstroms center-of-mass distances is printed in a matrix.
(BZ2)
S46 Dataset. ZAP-70 K377-ubiquitinated inactive simulation kinase-ubiquitin contact
matrix file. The fraction of the simulation snapshots where each pair of residues on ZAP-70
and ubiquitin are within 10 Angstroms center-of-mass distances is printed in a matrix.
(BZ2)
S47 Dataset. ZAP-70 K476-ubiquitinated active simulation kinase-ubiquitin contact
matrix file. The fraction of the simulation snapshots where each pair of residues on ZAP-70
and ubiquitin are within 10 Angstroms center-of-mass distances is printed in a matrix.
(BZ2)
S48 Dataset. ZAP-70 K476-ubiquitinated inactive simulation kinase-ubiquitin contact
matrix file. The fraction of the simulation snapshots where each pair of residues on ZAP-70
and ubiquitin are within 10 Angstroms center-of-mass distances is printed in a matrix.
(BZ2)
S49 Dataset. ZAP-70 K377-Ig domain active simulation kinase-ubiquitin contact matrix
file. The fraction of the simulation snapshots where each pair of residues on ZAP-70 and the Ig
domain are within 10 Angstroms center-of-mass distances is printed in a matrix.
(BZ2)
S50 Dataset. ZAP-70 active simulation kinase domain solvent accessible surface area file.
The solvent accessible surface area of the ZAP-70 kinase domain at each picosecond in the sim-
ulations is printed. Data from each of the 32 10-ns simulations is combined into one file.
(BZ2)
S51 Dataset. ZAP-70 inactive simulation kinase domain solvent accessible surface area file.
The solvent accessible surface area of the ZAP-70 kinase domain at each picosecond in the sim-
ulations is printed. Data from each of the 32 10-ns simulations is combined into one file.
(BZ2)
S52 Dataset. ZAP-70 K377-ubiquitinated active simulation kinase domain solvent accessi-
ble surface area file. The solvent accessible surface area of the ZAP-70 kinase domain at each
picosecond in the simulations is printed. Data from each of the 32 10-ns simulations is com-
bined into one file.
(BZ2)
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S53 Dataset. ZAP-70 K377-ubiquitinated active simulation ubiquitin moiety solvent acces-
sible surface area file. The solvent accessible surface area of the ubiquitin moiety at each pico-
second in the simulations is printed. Data from each of the 32 10-ns simulations is combined
into one file.
(BZ2)
S54 Dataset. ZAP-70 K377-ubiquitinated active simulation total solvent accessible surface
area file. The solvent accessible surface area of the entire ubiquitinated ZAP-70 at each pico-
second in the simulations is printed. Data from each of the 32 10-ns simulations is combined
into one file.
(BZ2)
S55 Dataset. ZAP-70 K377-ubiquitinated inactive simulation kinase domain solvent acces-
sible surface area file. The solvent accessible surface area of the ZAP-70 kinase domain at each
picosecond in the simulations is printed. Data from each of the 32 10-ns simulations is com-
bined into one file.
(BZ2)
S56 Dataset. ZAP-70 K377-ubiquitinated inactive simulation ubiquitin moiety solvent
accessible surface area file. The solvent accessible surface area of the ubiquitin moiety at each
picosecond in the simulations is printed. Data from each of the 32 10-ns simulations is com-
bined into one file.
(BZ2)
S57 Dataset. ZAP-70 K377-ubiquitinated inactive simulation total solvent accessible sur-
face area file. The solvent accessible surface area of the entire ubiquitinated ZAP-70 at each
picosecond in the simulations is printed. Data from each of the 32 10-ns simulations is com-
bined into one file.
(BZ2)
S58 Dataset. ZAP-70 K476-ubiquitinated active simulation kinase domain solvent accessi-
ble surface area file. The solvent accessible surface area of the ZAP-70 kinase domain at each
picosecond in the simulations is printed. Data from each of the 32 10-ns simulations is com-
bined into one file.
(BZ2)
S59 Dataset. ZAP-70 K476-ubiquitinated active simulation ubiquitin moiety solvent acces-
sible surface area file. The solvent accessible surface area of the ubiquitin moiety at each pico-
second in the simulations is printed. Data from each of the 32 10-ns simulations is combined
into one file.
(BZ2)
S60 Dataset. ZAP-70 K476-ubiquitinated active simulation total solvent accessible surface
area file. The solvent accessible surface area of the entire ubiquitinated ZAP-70 at each pico-
second in the simulations is printed. Data from each of the 32 10-ns simulations is combined
into one file.
(BZ2)
S61 Dataset. ZAP-70 K476-ubiquitinated inactive simulation kinase domain solvent acces-
sible surface area file. The solvent accessible surface area of the ZAP-70 kinase domain at each
picosecond in the simulations is printed. Data from each of the 32 10-ns simulations is com-
bined into one file.
(BZ2)
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S62 Dataset. ZAP-70 K476-ubiquitinated inactive simulation ubiquitin moiety solvent
accessible surface area file. The solvent accessible surface area of the ubiquitin moiety at each
picosecond in the simulations is printed. Data from each of the 32 10-ns simulations is com-
bined into one file.
(BZ2)
S63 Dataset. ZAP-70 K476-ubiquitinated inactive simulation total solvent accessible sur-
face area file. The solvent accessible surface area of the entire ubiquitinated ZAP-70 at each
picosecond in the simulations is printed. Data from each of the 32 10-ns simulations is com-
bined into one file.
(BZ2)
S1 File. UBK library file. Ubiquitinated lysine library file for input into tleap.
(LIB)
S2 File. ZAP-70 active structure Amber parameter file. Amber parameter file output from
tleap, used for running Amber simulations.
(BZ2)
S3 File. ZAP-70 active structure Amber starting structure file. Amber starting structure file
output from tleap, created from ZAP-70 pdb file.
(BZ2)
S4 File. ZAP-70 inactive structure Amber parameter file. Amber parameter file output from
tleap, used for running Amber simulations.
(BZ2)
S5 File. ZAP-70 inactive structure Amber starting structure file. Amber starting structure
file output from tleap, created from ZAP-70 pdb file.
(BZ2)
S6 File. ZAP-70 K377-ubiquitinated active structure Amber parameter file. Amber parame-
ter file output from tleap, used for running Amber simulations.
(BZ2)
S7 File. ZAP-70 K377-ubiquitinated active structure Amber starting structure file. Amber
starting structure file output from tleap, created from ZAP-70 pdb file.
(BZ2)
S8 File. ZAP-70 K377-ubiquitinated inactive structure Amber parameter file. Amber
parameter file output from tleap, used for running Amber simulations.
(BZ2)
S9 File. ZAP-70 K377-ubiquitinated inactive structure Amber starting structure file.
(BZ2)
S10 File. ZAP-70 K476-ubiquitinated active structure Amber parameter file. Amber param-
eter file output from tleap, used for running Amber simulations.
(BZ2)
S11 File. ZAP-70 K476-ubiquitinated active structure Amber starting structure file. Amber
starting structure file output from tleap, created from ZAP-70 pdb file.
(BZ2)
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S12 File. ZAP-70 K476-ubiquitinated inactive structure Amber parameter file. Amber
parameter file output from tleap, used for running Amber simulations.
(BZ2)
S13 File. ZAP-70 K476-ubiquitinated inactive structure Amber starting structure file.
Amber starting structure file output from tleap, created from ZAP-70 pdb file.
(BZ2)
S14 File. ZAP-70 K377-acetylated active structure Amber parameter file. Amber parameter
file output from tleap, used for running Amber simulations.
(BZ2)
S15 File. ZAP-70 K377-acetylated active structure Amber starting structure file. Amber
starting structure file output from tleap, created from ZAP-70 pdb file.
(BZ2)
S16 File. ZAP-70 K476-acetylated inactive structure Amber parameter file. Amber parame-
ter file output from tleap, used for running Amber simulations.
(BZ2)
S17 File. ZAP-70 K476-acetylated inactive structure Amber starting structure file.
(BZ2)
S18 File. ZAP-70 K377-Ig domain active structure Amber parameter file. Amber parameter
file output from tleap, used for running Amber simulations.
(BZ2)
S19 File. ZAP-70 K377-Ig domain active structure Amber starting structure file. Amber
starting structure file output from tleap, created from ZAP-70 pdb file.
(BZ2)
S20 File. Example ZAP-70 cpptraj trajectory analysis script. This is the cpptraj analysis script
for the active structure. The analysis commands for each of the 9 ZAP-70 constructs were the
same.
(PTRAJ)
S21 File. Example ZAP-70 ptraj trajectory distance matrix analysis script. This is one of the
ptraj scripts to calculate distance matrices to create a kinase-ubiquitin contact map for the
K377-ubiquitinated active structure. The rest of the trajectory was analyzed in additional scripts.
The analysis commands for each of the four ubiquitinated ZAP-70 constructs were the same.
(PTRAJ)
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